$CLVS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Clovis Oncology, Inc.. Get notifications about new insider transactions in Clovis Oncology, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | SCHOEMAKER KATHLEEN K | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOVEY BRIAN H | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,686 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 267,755 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 4,027 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 639,403 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,861 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 295,404 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,861 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Option Exercise | C | 0.00 | 295,404 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Buy | P | 0.00 | 4,165 | 0 | 13,600 | 9.4 K to 13.6 K (+44.14 %) |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | Versant Venture Capital IV, L. ... | 10% Owner | Buy | P | 0.00 | 661,323 | 0 | 2,159,289 | 1.5 M to 2.2 M (+44.15 %) |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 1,686 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 267,755 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 4,027 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 639,403 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 1,861 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 295,404 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 1,861 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 295,404 | 0 | 0 | |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 45,171 | 0 | 45,171 | 0 to 45.2 K |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | P | 0.00 | 4,165 | 0 | 13,600 | 9.4 K to 13.6 K (+44.14 %) |
Nov 17 2011 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | P | 0.00 | 661,323 | 0 | 2,159,289 | 1.5 M to 2.2 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |